147 related articles for article (PubMed ID: 35771004)
1. Psychosocial Effects of the Loop Open-Source Automated Insulin Delivery System.
Wong JJ; Hood KK; Hanes SJ; Lal RA; Naranjo D
J Diabetes Sci Technol; 2023 Nov; 17(6):1440-1447. PubMed ID: 35771004
[TBL] [Abstract][Full Text] [Related]
2. How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: Findings from the first investigation with the Omnipod® 5 System.
Polonsky WH; Hood KK; Levy CJ; MacLeish SA; Hirsch IB; Brown SA; Bode BW; Carlson AL; Shah VN; Weinstock RS; Bhargava A; Jones TC; Aleppo G; Mehta SN; Laffel LM; Forlenza GP; Sherr JL; Huyett LM; Vienneau TE; Ly TT;
Diabetes Res Clin Pract; 2022 Aug; 190():109998. PubMed ID: 35853530
[TBL] [Abstract][Full Text] [Related]
3. Psychosocial and Human Factors During a Trial of a Hybrid Closed Loop System for Type 1 Diabetes Management.
Adams RN; Tanenbaum ML; Hanes SJ; Ambrosino JM; Ly TT; Maahs DM; Naranjo D; Walders-Abramson N; Weinzimer SA; Buckingham BA; Hood KK
Diabetes Technol Ther; 2018 Oct; 20(10):648-653. PubMed ID: 30239219
[TBL] [Abstract][Full Text] [Related]
4. The Influence of Real-Time Continuous Glucose Monitoring on Psychosocial Outcomes in Insulin-Using Type 2 Diabetes.
Soriano EC; Polonsky WH
J Diabetes Sci Technol; 2023 Nov; 17(6):1614-1622. PubMed ID: 35533137
[TBL] [Abstract][Full Text] [Related]
5. Reexamining the Hypoglycemia Fear Survey for Parents of Young Children in a Sample of Children Using Insulin Pumps.
Patton SR; Noser AE; Clements MA; Dolan LM; Powers SW
Diabetes Technol Ther; 2017 Feb; 19(2):103-108. PubMed ID: 28118046
[TBL] [Abstract][Full Text] [Related]
6. Effect of 6 months of hybrid closed-loop insulin delivery in adults with type 1 diabetes: a randomised controlled trial protocol.
McAuley SA; de Bock MI; Sundararajan V; Lee MH; Paldus B; Ambler GR; Bach LA; Burt MG; Cameron FJ; Clarke PM; Cohen ND; Colman PG; Davis EA; Fairchild JM; Hendrieckx C; Holmes-Walker DJ; Horsburgh JC; Jenkins AJ; Kaye J; Keech AC; King BR; Kumareswaran K; MacIsaac RJ; McCallum RW; Nicholas JA; Sims C; Speight J; Stranks SN; Trawley S; Ward GM; Vogrin S; Jones TW; O'Neal DN
BMJ Open; 2018 Jun; 8(6):e020274. PubMed ID: 29886443
[TBL] [Abstract][Full Text] [Related]
7. Improvement in Psychosocial Outcomes in Children with Type 1 Diabetes and Their Parents Following Subsidy for Continuous Glucose Monitoring.
Burckhardt MA; Abraham MB; Mountain J; Coenen D; Paniora J; Clapin H; Jones TW; Davis EA
Diabetes Technol Ther; 2019 Oct; 21(10):575-580. PubMed ID: 31335192
[No Abstract] [Full Text] [Related]
8. Sustained Impact of Real-time Continuous Glucose Monitoring in Adults With Type 1 Diabetes on Insulin Pump Therapy: Results After the 24-Month RESCUE Study.
Charleer S; De Block C; Nobels F; Radermecker RP; Lowyck I; Mullens A; Scarnière D; Spincemaille K; Strivay M; Weber E; Taes Y; Vercammen C; Keymeulen B; Mathieu C; Gillard P;
Diabetes Care; 2020 Dec; 43(12):3016-3023. PubMed ID: 33067260
[TBL] [Abstract][Full Text] [Related]
9. Psychosocial Outcomes Among Users and Nonusers of Open-Source Automated Insulin Delivery Systems: Multinational Survey of Adults With Type 1 Diabetes.
Schipp J; Hendrieckx C; Braune K; Knoll C; O'Donnell S; Ballhausen H; Cleal B; Wäldchen M; Lewis DM; Gajewska KA; Skinner TC; Speight J
J Med Internet Res; 2023 Dec; 25():e44002. PubMed ID: 38096018
[TBL] [Abstract][Full Text] [Related]
10. Six months of hybrid closed loop in the real-world: An evaluation of children and young adults using the 670G system.
Berget C; Messer LH; Vigers T; Frohnert BI; Pyle L; Wadwa RP; Driscoll KA; Forlenza GP
Pediatr Diabetes; 2020 Mar; 21(2):310-318. PubMed ID: 31837064
[TBL] [Abstract][Full Text] [Related]
11. Extended Use of an Open-Source Automated Insulin Delivery System in Children and Adults with Type 1 Diabetes: The 24-Week Continuation Phase Following the CREATE Randomized Controlled Trial.
Burnside MJ; Lewis DM; Crocket HR; Meier RA; Williman JA; Sanders OJ; Jefferies CA; Faherty AM; Paul RG; Lever CS; Price SKJ; Frewen CM; Jones SD; Gunn TC; Lampey C; Wheeler BJ; de Bock MI
Diabetes Technol Ther; 2023 Apr; 25(4):250-259. PubMed ID: 36763345
[No Abstract] [Full Text] [Related]
12. Positive Impact of the Bionic Pancreas on Diabetes Control in Youth 6-17 Years Old with Type 1 Diabetes: A Multicenter Randomized Trial.
Messer LH; Buckingham BA; Cogen F; Daniels M; Forlenza G; Jafri RZ; Mauras N; Muir A; Wadwa RP; White PC; Russell SJ; Damiano ER; El-Khatib FH; Ruedy KJ; Balliro CA; Li Z; Marak MC; Calhoun P; Beck RW
Diabetes Technol Ther; 2022 Oct; 24(10):712-725. PubMed ID: 36173237
[No Abstract] [Full Text] [Related]
13. Fear of hypoglycemia in children with type 1 diabetes and their parents: Effect of pump therapy and continuous glucose monitoring with option of low glucose suspend in the CGM TIME trial.
Verbeeten KC; Perez Trejo ME; Tang K; Chan J; Courtney JM; Bradley BJ; McAssey K; Clarson C; Kirsch S; Curtis JR; Mahmud FH; Richardson C; Cooper T; Lawson ML;
Pediatr Diabetes; 2021 Mar; 22(2):288-293. PubMed ID: 33179818
[TBL] [Abstract][Full Text] [Related]
14. Sleep and diabetes-specific psycho-behavioral outcomes of a new automated insulin delivery system in young children with type 1 diabetes and their parents.
Bisio A; Brown SA; McFadden R; Pajewski M; Yu PL; DeBoer M; Schoelwer MJ; Bonner HG; Wakeman CA; Cherñavvsky DR; Gonder-Frederick L
Pediatr Diabetes; 2021 May; 22(3):495-502. PubMed ID: 33289242
[TBL] [Abstract][Full Text] [Related]
15. Impact of the Hybrid Closed-Loop System on Sleep and Quality of Life in Youth with Type 1 Diabetes and Their Parents.
Cobry EC; Hamburger E; Jaser SS
Diabetes Technol Ther; 2020 Nov; 22(11):794-800. PubMed ID: 32212971
[No Abstract] [Full Text] [Related]
16. Impact of 6-months of an advanced hybrid closed-loop system on sleep and psychosocial outcomes in youth with type 1 diabetes and their parents.
Cobry EC; Pyle L; Karami AJ; Sakamoto C; Meltzer LJ; Jost E; Towers L; Paul Wadwa R
Diabetes Res Clin Pract; 2024 Jan; 207():111087. PubMed ID: 38181984
[TBL] [Abstract][Full Text] [Related]
17. Do-It-Yourself (DIY) Artificial Pancreas Systems for Type 1 Diabetes: Perspectives of Two Adult Users, Parent of a User and Healthcare Professionals.
Ahmed SH; Ewins DL; Bridges J; Timmis A; Payne N; Mooney C; MacGregor C
Adv Ther; 2020 Sep; 37(9):3929-3941. PubMed ID: 32696329
[TBL] [Abstract][Full Text] [Related]
18. Comparison of treatment with continuous subcutaneous insulin infusion versus multiple daily insulin injections with bolus calculator in patients with type 1 diabetes.
Pérez-García L; Goñi-Iriarte MJ; García-Mouriz M
Endocrinol Nutr; 2015; 62(7):331-7. PubMed ID: 26234808
[TBL] [Abstract][Full Text] [Related]
19. Strengths and Challenges of Closed-Loop Insulin Delivery During Exercise in People With Type 1 Diabetes: Potential Future Directions.
Paldus B; Morrison D; Lee M; Zaharieva DP; Riddell MC; O'Neal DN
J Diabetes Sci Technol; 2023 Jul; 17(4):1077-1084. PubMed ID: 35466723
[TBL] [Abstract][Full Text] [Related]
20. Fear of hypoglycemia in type 1 diabetes managed by continuous subcutaneous insulin infusion: is it associated with poor glycemic control?
Nixon R; Pickup JC
Diabetes Technol Ther; 2011 Feb; 13(2):93-8. PubMed ID: 21284474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
